Stuart Henderson
Director/Board Member presso OXFORD BIOMEDICA PLC
Patrimonio netto: 27 580 $ in data 31/03/2024
Profilo
Stuart Henderson is currently the Non-Executive Vice Chairman at Oxford Biomedica Plc since 2020.
Previously, he served as the Director at BioCity Group Ltd from 2018 to 2021.
He also held positions as the Director at The Babraham Institute, One Nucleus Ltd., and Norwich Research Partners LLP.
Additionally, he served as a Non-Executive Director at Cell Therapy Catapult Ltd.
Mr. Henderson was a Partner at Deloitte LLP (United Kingdom) and worked at Arthur Andersen LLP from 2004 to 2005.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
OXFORD BIOMEDICA PLC
0.01% | 20/09/2023 | 10 862 ( 0.01% ) | 27 580 $ | 31/03/2024 |
Posizioni attive di Stuart Henderson
Società | Posizione | Inizio |
---|---|---|
OXFORD BIOMEDICA PLC | Director/Board Member | 01/06/2016 |
Precedenti posizioni note di Stuart Henderson
Società | Posizione | Fine |
---|---|---|
BioCity Group Ltd
BioCity Group Ltd Investment ManagersFinance BioCity Nottingham Ltd (BioCity) is a venture capital firm founded in 2002. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 30/04/2021 |
Deloitte LLP (United Kingdom)
Deloitte LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte LLP (United Kingdom) provides brokerage services. The private company is based in London, UK. David Sproul has been the CEO of the British company since 2003. | Corporate Officer/Principal | - |
Cell Therapy Catapult Ltd.
Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Director/Board Member | - |
Norwich Research Partners LLP
Norwich Research Partners LLP Miscellaneous Commercial ServicesCommercial Services Norwich Research Partners LLP operates as a business community. The private company is based in Norwich, UK. The British company was founded in 2012. The CEO is David Parfrey. | Director/Board Member | - |
One Nucleus Ltd.
One Nucleus Ltd. Miscellaneous Commercial ServicesCommercial Services One Nucleus Ltd. is a life science membership organization that supports the largest life science cluster in the East of England region through knowledge transfer, connectivity, inward investment, and growth. The non-profit company is based in Cambridge, UK. Sphere Fluidics, a British company commercializing single cell analysis systems, introduced the Cyto-Cellect™ Human IgGK Detection Kit, to be used in conjunction with the Cyto-Mine® Single Cell Analysis System for rapid and cost-effective measurement of antibody class and productivity in cell. Marks & Clerk, a global intellectual property firm, announced that Associates Graham McGlashan and Erik Rõuk will be attending the 7th International XR Conference, taking place in partnership with The Manchester Metropolitan University, ISCTE - Instituto Universitario de Lisboa and the International Association of Immersive Technology Innovation. BioIVT, a leading provider of research models and services for drug and diagnostic development, recently acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera, and controls. | Director/Board Member | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
OXFORD BIOMEDICA PLC | Health Technology |
Aziende private | 6 |
---|---|
BioCity Group Ltd
BioCity Group Ltd Investment ManagersFinance BioCity Nottingham Ltd (BioCity) is a venture capital firm founded in 2002. The firm is headquartered in London, United Kingdom. | Finance |
The Babraham Institute
The Babraham Institute Miscellaneous Commercial ServicesCommercial Services Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB. | Commercial Services |
Deloitte LLP (United Kingdom)
Deloitte LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte LLP (United Kingdom) provides brokerage services. The private company is based in London, UK. David Sproul has been the CEO of the British company since 2003. | Commercial Services |
One Nucleus Ltd.
One Nucleus Ltd. Miscellaneous Commercial ServicesCommercial Services One Nucleus Ltd. is a life science membership organization that supports the largest life science cluster in the East of England region through knowledge transfer, connectivity, inward investment, and growth. The non-profit company is based in Cambridge, UK. Sphere Fluidics, a British company commercializing single cell analysis systems, introduced the Cyto-Cellect™ Human IgGK Detection Kit, to be used in conjunction with the Cyto-Mine® Single Cell Analysis System for rapid and cost-effective measurement of antibody class and productivity in cell. Marks & Clerk, a global intellectual property firm, announced that Associates Graham McGlashan and Erik Rõuk will be attending the 7th International XR Conference, taking place in partnership with The Manchester Metropolitan University, ISCTE - Instituto Universitario de Lisboa and the International Association of Immersive Technology Innovation. BioIVT, a leading provider of research models and services for drug and diagnostic development, recently acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera, and controls. | Commercial Services |
Norwich Research Partners LLP
Norwich Research Partners LLP Miscellaneous Commercial ServicesCommercial Services Norwich Research Partners LLP operates as a business community. The private company is based in Norwich, UK. The British company was founded in 2012. The CEO is David Parfrey. | Commercial Services |
Cell Therapy Catapult Ltd.
Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Stuart Henderson